True Open Access: No submission, publication or reading charges  

 eCM Home

 

Journal

Conferences

 eCM Journal Issues

 

Issues

Supplements

 About eCM Journal

 

 Scope & Info

 Submission

 Editors

 Societies & Sponsors

 Contact

 eCM Related Info

 

 Meetings

 Links

 eCM Paper notification

 

  (Info)

 eCM Site search

 
 
 
 

Please Visit Our
Sponsors

 


eCM Scope

eCM provides an interdisciplinary forum for publication of preclinical research in the musculoskeletal field (Trauma, Maxillofacial (including dental), Spine and Orthopaedics) and the cells and materials used in the replacement, repair or regeneration of these tissues.

The clinical relevance of the work must be briefly mentioned within the abstract, and in more detail in the discussion.Poor abstracts which do not concisely cover the paper contents will not be sent for review. Incremental steps in research will not be entertained by eCM journal.
Please CAREFULLY read the Instructions to Authors before submission to save early disappointment.

Cross-disciplinary papers that go across our scope areas are welcomed.

• Assessment of materials for biomedical use in the musculoskeletal field & interaction with tissues/ prokaryotic / eukaryotic cells.
Manuscripts must have an important biological dimension reporting effects at the cellular, tissue or organismic levels. Papers focussing purely on material properties will not be entertained. In vitro cytocompatibilty studies should use primary cells or more than one cell line and provide more than just simple descriptions of cell viability, spreading, proliferation, mineralisation etc. Major improvement in in vitro or in vivo models are considered.
Note:
Submissions of manuscripts on effects of surfaces, coatings, additives etc. to prevent bacterial adhesion must also consider the effect on eukaryotic cells (to be mentioned within the abstract) or refer to previously published data with the exact same surfaces to be considered for publication. High level submissions on Infection prevention, diagnostics, therapy and major improvement in in vitro or in vivo models are welcomed.

• Tissue Engineering and Regenerative Medicine.
Manuscripts concerning aspects of the repair or regeneration of connective and mineralized tissues within the musculoskeletal field will be considered.

Structure, function, biology of connective and mineralized tissues.
Manuscripts concerning the structure of bone, teeth, cartilage, intervertebral discs, skeletal muscle, tendons and ligaments within the musculoskeletal field will be considered.

Stem and Progenitor Cells.
All manuscripts concerning stem cell characterization and mechanisms of differentiation as they relate to the connective and mineralized tissues of the musculoskeletal field will be considered. Note: The use of pooled donor cells should be avoided. When unavoidable, their use needs to be justified convincingly within the manuscript (and within the cover letter).

eCM carries original research papers, reviews and tutorials on the advances made within the journal scope. All articles are peer-reviewed and reviewer comments, together with responses by authors, are published as an integral part of the paper. Technical notes are not entertained.

Note: musculoskeletal field includes bone, teeth, cartilage, intervertebral discs, skeletal muscle (not smooth or cardiac muscle), tendons and ligaments.

Ten good reasons for publishing a paper in eCM
1. World-wide ‘True Open access’: No submission, publication or reading charges of any kind (several commercial journals offer authors the option of making their article freely available at costs of 2000-5000$, with eCM it is free).
2. 12277 registered readers world-wide, over 3000 PubMed monthly linkouts & 6500 monthly visits (Google analytics).

3. Authors retain copyright to their articles.
4. 2010 Impact Factor 9.650 (2009 IF 5.378).
5.
Indexed by ISI within: Science Citation Index Expanded, Materials Science Citation Index, Journal Citation Reports /Science Edition, Biosis Previews and Biological abstracts. Also indexed in CAS, Index Medicus, Medline and Scopus databases and can be searched directly from Pubmed, Biomedsearch, DOAJ and Open J Gate.
6. Open high standard peer reviewing minimises both favouritism and prejudice.
7. Discussion with reviewers feature allows sensible arguments included in the paper.
8. Speed of publication, 40 days average from submission to first decision, ~3 weeks after acceptance, paper is online.
9. No payment for reprints: simply mail colleagues the web page address of the paper.
10. Founded by scientists for the benefit of Science rather than profit.

All papers are available in Portable Document File (PDF) format and require Adobe Acrobat Reader installed to be able to read them. No paper version is published.

 


   
 

Last modified October 21, 2011

Publisher: AO Foundation, Davos, Switzerland